Sarepta Therapeutics reported $15.83M in Interest Expense on Debt for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Alexion Pharmaceuticals ALXN:US $ 27.1M 0.6M
Alnylam Pharmaceuticals ALNY:US $ 33.42M 901K
Amgen AMGN:US $ 281M 4M
Arena Pharmaceuticals ARNA:US $ 1.05M 0.02M
Biocryst Pharmaceuticals BCRX:US $ 13.5M 0.59M
Biogen BIIB:US $ 56.4M 8.3M
Biomarin Pharmaceutical BMRN:US $ 3.82M 0.01M
Eli Lilly And LLY:US $ 86.9M 0.9M
Esperion Therapeutics ESPR:US $ 11.14M 3.02M
Gilead Sciences GILD:US $ 256M 1M
Gw Pharmaceuticals GWPH:US $ 0.29M 0.02M
Insmed INSM:US $ 10.32M 2.76M
Intercept Pharmaceuticals ICPT:US $ 12.59M 0.17M
IONIS PHARMACEUT IONS:US $ 2.36M 0.06M
Moderna Inc MRNA:US 5M 2M
Nektar Therapeutics NKTR:US $ 13.09M 0.21M
Neurocrine Biosciences NBIX:US $ 6.2M 0.2M
Newlink Genetics NLNK:US 0 37K
Novavax NVAX:US $ 5.97M 1.13M
Pfizer PFE:US $ 316M 20M
Ptc Therapeutics PTCT:US $ 22.56M 2.7M
Regeneron Pharmaceuticals REGN:US $ 14.4M 0.2M
Sarepta Therapeutics SRPT:US $ 15.83M 0.18M
Vertex Pharmaceuticals VRTX:US $ 15.48M 0.2M
YTE INCY:US $ 0.36M 0M
Zogenix ZGNX:US $ 3.79M 0.05M